Neoadjuvant and adjuvant trastuzumab in patients with HER2–positive locally advanced breast cancer (NOAH): follow–up of a randomised controlled superiority trial with a parallel HER2–negative cohort
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest